98. Eosinophilic gastrointestinal disease Clinical trials / Disease details


Clinical trials : 172 Drugs : 149 - (DrugBank : 39) / Drug target genes : 38 - Drug target pathways : 135

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00017862
(ClinicalTrials.gov)
June 200115/6/2001Anti-Interleukin-5 Antibody to Treat Hypereosinophilic SyndromeA Pilot Phase II Study of the Efficacy of Humanized Anti-IL5 Antibody (SCH55700) in Reducing Eosinophilia in Patients With Hypereosinophilic Syndrome or Eosinophilic Gastroenteritis Refractory to or Intolerant of Conventional TherapyHypereosinophilic SyndromeDrug: SCH55700National Institute of Allergy and Infectious Diseases (NIAID)NULLCompletedN/AN/ABoth10Phase 2United States